MET in ovarian cancer: Metastasis and resistance?

by Tang, Chad, Jardim, Denis L, Hong, David
Published 2014

Targeting translation initiation in breast cancer

by Akcakanat, Argun, Hong, David S, Meric-Bernstam, Funda
Published 2014

Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service

by Parsons, Henrique A., Baracos, Vickie E., Dhillon, Navjot, Hong, David S., Kurzrock, Razelle
Published 2012

Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients

by Subbiah, Vivek, Bupathi, Manojkumar, Kato, Shumei, Livingston, Andrew, Slopis, John, Anderson, Pete M., Hong, David S.
Published 2015

The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer

by Parsons, Henrique A., Baracos, Vickie E., Hong, David S., Abbruzzese, James, Bruera, Eduardo, Kurzrock, Razelle
Published 2016

The isolation and characterization of CTC subsets related to breast cancer dormancy

by Vishnoi, Monika, Peddibhotla, Sirisha, Yin, Wei, T. Scamardo, Antonio, George, Goldy C., Hong, David S., Marchetti, Dario
Published 2015

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

by El-Osta, Hazem, Falchook, Gerald, Tsimberidou, Apostolia, Hong, David, Naing, Aung, Kim, Kevin, Wen, Sijin, Janku, Filip, Kurzrock, Razelle
Published 2011

Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors

by Stewart, David J, Nunez, Maria I, Jelinek, Jaroslav, Hong, David, Gupta, Sanjay, Issa, Jean-Pierre, Wistuba, Ignacio I, Kurzrock, Razelle
Published 2014

Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors

by Naing, Aung, Fu, Siqing, Zinner, Ralph G., Wheler, Jennifer J., Hong, David S., Arakawa, Kazuhito, Falchook, Gerald S., Kurzrock, Razelle
Published 2013

A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma

by Subbiah, Vivek, Brown, Robert E., McGuire, Mary F., Buryanek, Jamie, Janku, Filip, Younes, Anas, Hong, David
Published 2013

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

by Janku, Filip, Lee, J. Jack, Tsimberidou, Apostolia M., Hong, David S., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Luthra, Rajyalakshmi, Garrido-Laguna, Ignacio, Kurzrock, Razelle
Published 2011

T cell receptor ligation induces the formation of dynamically regulated signaling assemblies

by Bunnell, Stephen C., Hong, David I., Kardon, Julia R., Yamazaki, Tetsuo, McGlade, C. Jane, Barr, Valarie A., Samelson, Lawrence E.
Published 2002

KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

by Garrido-Laguna, Ignacio, Hong, David S., Janku, Filip, Nguyen, Ly M., Falchook, Gerald S., Fu, Siqing, Wheler, Jenifer J., Luthra, Rajyalakshmi, Naing, Aung, Wang, Xuemei, Kurzrock, Razelle
Published 2012

Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses

by Wheler, Jennifer, Hong, David, Swisher, Stephen G., Falchook, Gerald, Tsimberidou, Apostolia M., Helgason, Thorunn, Naing, Aung, Stephen, Bettzy, Janku, Filip, Stephens, Philip J., Yelensky, Roman, Kurzrock, Razelle
Published 2013

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus

by Piha-Paul, Sarina A., Wheler, Jennifer J., Fu, Siqing, Levenback, Charles, Lu, Karen, Falchook, Gerald S., Naing, Aung, Hong, David S., Tsimberidou, Apostolia M., Kurzrock, Razelle
Published 2014

Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015

by Rolfo, Christian, Caglevic, Christian, Bretel, Denisse, Hong, David, Raez, Luis E, Cardona, Andres F, Oton, Ana B, Gomez, Henry, Dafni, Urania, Vallejos, Carlos, Zielinski, Christoph
Published 2016

Tumor kinetics prior to treatment correlate with response to checkpoint inhibitors

by Cadena, Alexandra P, Welsh, James, Tang, Chad, Raju, Uma, Hong, David, Naing, Aung, Godoy, Myrna, Allen, Pamela K, Schoenhals, Jonathan, Cortez, Maria Angelica
Published 2015

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

by Wheler, Jennifer, Yelensky, Roman, Falchook, Gerald, Kim, Kevin B, Hwu, Patrick, Tsimberidou, Apostolia M, Stephens, Philip J, Hong, David, Cronin, Maureen T, Kurzrock, Razelle
Published 2015

A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours

by Hong, David S., Kurzrock, Razelle, Mulay, Marilyn, Rasmussen, Erik, Wu, Benjamin M., Bass, Michael B., Zhong, Zhandong D., Friberg, Greg, Rosen, Lee S.
Published 2014

Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience

by Hou, Ming-Mo, Liu, Xiaochun, Wheler, Jennifer, Naing, Aung, Hong, David, Coleman, Robert L., Tsimberidou, Apostolia, Janku, Filip, Zinner, Ralph, Lu, Karen, Kurzrock, Razelle, Fu, Siqing
Published 2014